# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-016083
Filing Date
2025-04-28
Accepted
2025-04-28 17:26:37
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | edge20045980x2_defa14a.htm | DEFA14A | 9052
2 |  | edge20045980x2_nc01.jpg | GRAPHIC | 1222823
3 |  | edge20045980x2_nc02.jpg | GRAPHIC | 802712
| Complete submission text file | 0001140361-25-016083.txt |  | 2797313

Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14027 | Film No.: 25881670
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)